Michael Grabner

Summary

Affiliation: Health Outcomes Research
Country: USA

Publications

  1. doi Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level
    Michael Grabner
    HealthCore, Inc, Wilmington, Delaware Electronic address
    Am J Cardiol 119:404-409. 2017
  2. doi Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population
    Michael Grabner
    HealthCore, Inc, Wilmington, DE, USA Electronic address
    J Sex Med 14:88-97. 2017
  3. ncbi Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population
    Michael Grabner
    HealthCore, 123 Justison St, Ste 200, Wilmington, DE 19801
    J Manag Care Spec Pharm 21:1204-12. 2015
  4. doi Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial
    Michael Grabner
    HealthCore, Inc, Wilmington, DE 19801, USA
    Postgrad Med 125:204-13. 2013

Detail Information

Publications5

  1. doi Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level
    Michael Grabner
    HealthCore, Inc, Wilmington, Delaware Electronic address
    Am J Cardiol 119:404-409. 2017
    ..In conclusion, LDL-lowering therapy guided by LDL-P was demonstrated to be cost effective, with greater clinical and economic benefit seen over longer time horizons and with the increased use of generic statins...
  2. doi Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population
    Michael Grabner
    HealthCore, Inc, Wilmington, DE, USA Electronic address
    J Sex Med 14:88-97. 2017
    ..Hypogonadism is broadly associated with increases in chronic comorbid conditions and health care costs. Little is known about the specific impact of primary and secondary hypogonadism on health care costs...
  3. ncbi Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population
    Michael Grabner
    HealthCore, 123 Justison St, Ste 200, Wilmington, DE 19801
    J Manag Care Spec Pharm 21:1204-12. 2015
    ..Approved less than 2 years ago, use of canagliflozin is largely uncharacterized...
  4. doi Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial
    Michael Grabner
    HealthCore, Inc, Wilmington, DE 19801, USA
    Postgrad Med 125:204-13. 2013
    ....